Ticker Symbol: ALLR
Allarity Therapeutics Inc
Exchange: NASDAQ
Currency:
USD
Asset
Type: Common Stock
CIK:0001860657
Company Profile
oncology venture is a drug development company formed in 2012 dedicated to unlock the potential of new oncology products, and rescue failed drugs. our method improves the efficacy of the drugs, increase the response rate in cancer patients, reduce timelines and improve success rates in oncology drug development.
Sector: Professional, Scientific, and Technical Services
Industry: Research and Development in Biotechnology
Standard Industrial Classification Code (SIC code): 2834
Address: N/A
Website: N/A
CEO: N/A
Tags:
N/A
Pricing
Last Updated: October 20, 2023 03:00 PM EST
Previous Close: $0.65
Change:
-$0.05
(
-7.14%)
Days Range: $0.63 - $0.71
Beta: 0.91
52wk. High: $1,890.00
52wk. Low: $0.63
Ytd. Change -106.98%
50 Day Moving Average: $0.88
200 Day Moving Average: $9.43
Shares Outstanding: 4185623
Valuation
Market Cap: 272.1M
PE Ratio: -
EPS (TTM): 0
Dividends
Dividend Per Share (TTM): -
Dividend Yield (TTM): 0.00%
Ex-Dividend Date: N/A